These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8557344)

  • 1. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
    Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
    Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
    Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
    Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
    Kotloff KL; Noriega F; Losonsky GA; Sztein MB; Wasserman SS; Nataro JP; Levine MM
    Infect Immun; 1996 Nov; 64(11):4542-8. PubMed ID: 8890204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
    Noriega FR; Losonsky G; Lauderbaugh C; Liao FM; Wang JY; Levine MM
    Infect Immun; 1996 Aug; 64(8):3055-61. PubMed ID: 8757833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
    Noriega FR; Wang JY; Losonsky G; Maneval DR; Hone DM; Levine MM
    Infect Immun; 1994 Nov; 62(11):5168-72. PubMed ID: 7927802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.
    Alexander WA; Hartman AB; Oaks EV; Venkatesan MM
    Vaccine; 1996 Aug; 14(11):1053-61. PubMed ID: 8879102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

  • 11. Construction of a novel Shigella live-vector strain co-expressing CS3 and LTB/STm of enterotoxigenic E.coli.
    Zheng JP; Zhang ZS; Li SQ; Liu XX; Yuan SL; Wang P; Zhan DW; Wang LC; Huang CF
    World J Gastroenterol; 2005 Jun; 11(22):3411-8. PubMed ID: 15948247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.
    Hartman AB; Van de Verg LL; Collins HH; Tang DB; Bendiuk NO; Taylor DN; Powell CJ
    Infect Immun; 1994 Feb; 62(2):412-20. PubMed ID: 7507892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.
    Barry EM; Altboum Z; Losonsky G; Levine MM
    Vaccine; 2003 Jan; 21(5-6):333-40. PubMed ID: 12531629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli.
    Ranallo RT; Fonseka CP; Cassels F; Srinivasan J; Venkatesan MM
    Infect Immun; 2005 Jan; 73(1):258-67. PubMed ID: 15618162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simultaneous expression of CS3 colonization factor antigen and LT-B/ST fusion enterotoxin antigen of enterotoxigenic Escherichia coli by attenuated Shigella flexneri 2a].
    Liu TT; Li SQ; Zhang ZS; Zheng JP; Liu XL; Luo G; Huang CF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):49-54. PubMed ID: 12518227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
    Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
    Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
    Ranallo RT; Fonseka S; Boren TL; Bedford LA; Kaminski RW; Thakkar S; Venkatesan MM
    Vaccine; 2012 Jul; 30(34):5159-71. PubMed ID: 22658966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.